Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

Background: Concern exists that the clinical trial populations differ from respective cancer populations in terms of their age distribution affecting the generalizability of the results, especially in underrepresented minorities. We hypothesized that the clinical trials that do not report race are l...

Full description

Bibliographic Details
Main Authors: Thejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen, Meghna Ailawadhi, Ayesha Samreen, Ricardo Parrondo, Taimur Sher, Vivek Roy, Rami Manochakian, Aneel Paulus, Asher Chanan-Khan, Sikander Ailawadhi
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
clinical trials
cancer
disparity
age
race
Online Access:https://www.mdpi.com/2072-6694/13/22/5770

Internet

https://www.mdpi.com/2072-6694/13/22/5770

Similar Items